358570 — GI Innovation Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for GI Innovation, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-75,933	-150,742	-79,833	-55,022	-59,007
Depreciation
Amortisation
Non-Cash Items	55,417	124,778	17,471	8,927	14,998
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	4,156	-2,761	-3,345	1,592	-2,519
Change in Accounts Receivable
Change in Other Assets
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-15,182	-26,577	-62,550	-41,174	-43,427
Capital Expenditures	-3,213	-4,922	-2,970	-579	-24.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-8,121	-134,249	65,954	22,842	15,275
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-11,334	-139,171	62,984	22,263	15,250
Financing Cash Flow Items	30,700	-62.5	—	-801	-140
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	31,435	161,492	-32.1	25,109	20,617
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4,919	-4,256	402	6,198	-7,560